Tokyo, Oct. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059572) titled 'The Study on the Pathophysiology of Psychiatric Symptoms Induced by Antibodies against Neurotransmission-related Molecules' on Oct. 29.
Study Type:
Observational
Primary Sponsor:
Institute - University of Toyama
Condition:
Condition - Schizophrenia, First-Episode Psychosis (FEP), At-Risk Mental State (ARMS), Healthy Control
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to measure autoantibodies against neurotransmission-related molecules, such as NMDA receptors, neurexin1, and NCAM1, in blood samples from patients with schizophrenia, first-episod...